Job Description
Description
This individual will work across various clinical projects across the FDA Office of Computational Sciences supporting the responsibilities below :
- Participating as a subject matter expert for any clinical safety studies, respectively, which are submitted to the FDA in support of drug applications.
- Reviewing clinical data for regulatory compliance to ensure human subject safety and data integrity and communicating findings with a multi-disciplinary review team.
- Completing special projects that involve specific research areas and objectives to include the design, characterization, performance, and bioequivalence of complex drug products; development of advanced manufacturing approaches for drug substances and drug products; development of science-based drug quality standards; and the development of analytical and in-vitro methods to support product quality surveillance and investigate product quality failures.
- Serving as a CDER resource by participating in work groups or subcommittees.
- Publishing scientific articles within the scientist's area of expertise and maintaining contact with the "state of science” to identify and integrate the most advanced research theories and / or practices into the Center's drug regulatory programs.
Essential Skills and Experience :
Minimum of 5 years experience as a reviewer scientist working on drug applications of various typesAdditional Desired Skills and Experience :
Strong project management skillsExperience with clinical informatics and the IT systems that support themExperience with clinical analytical tools such as MAED (or other Adverse Events Analysis Software), JMP / JMP Clinical, Pinnacle21 Data Validation EngineExperience with data standards such as CDISC Data Standards (SDTM / ADaM) and MedDRAExperience leading clinical trials and shaping clinical trial designExperience at FDA or in the pharma industry extending beyond primary clinical reviewExperience with conducting safety reviews and clinical data analyticsExperience with creating safety analysis to evaluate drug safety and efficacyExperience working with medical reviewersExperience with drafting information requests (IRs) from FDA and / or responding to them on behalf of industryExpertise in identifying the type of analysis that may be limited by the data providedExpertise in identifying areas of weakness in clinical submissions based on study design and provided data